NorthWest Biotherapeutics Inc (NWBO)

[hmuney]

Patent granted on July 15, 2022 for MX/a/2018/003197 ???? - Methods relating to activated dendritic cell compositions and immunotherapeutic treatments for subjects with advanced cancers

1. https://vidoc.impi.gob.mx/DocVidoc.aspx?param=yWmOEtsT7jnuseUu9PjM0HojOoSkFfDU
2. https://patentscope.wipo.int/search/en/detail.jsf?docId=MX234853107
3.

$NWBO Patent granted on July 15, 2022 for MX/a/2018/003197 🇲🇽 - Methods relating to activated dendritic cell compositions and immunotherapeutic treatments for subjects with advanced cancers

1. https://t.co/eImO2MqVdL
2. https://t.co/kmm9jINl1Q pic.twitter.com/1jq2XNJIpm

— Henry (@HenryMuney) August 2, 2022

----------
Vigencia: Veinte años
Fecha de Vencimiento: 14 de septiembre de 2036
Fecha de Expedición: 15 de julio de 2022

La patente de referencia se otorga con fundamento en los artículos 1º, 2º fracción V, 6º fracción III, y 59 de la Ley de la Propiedad Industrial.

Translation:

Validity: Twenty years
Expiration Date: September 14, 2036
Issue Date: July 15, 2022

The reference patent is granted based on articles 1, 2, section V, 6, section III, and 59 of the Industrial Property Law.
----------